XRAISED | Revolutionizing Birth Control: The Future of Male Contraception with Plan A™

ORIGINALLY POSTED ON: XRAISED

In this groundbreaking interview, Dr. Darlene Walley—biotech leader and CEO of NEXT Life Sciences—shares the bold vision behind Plan A™, the world’s first long-lasting, non-hormonal, and reversible male contraceptive in development.

With decades of success in healthcare innovation and over $1B in company exits, Dr. Walley discusses why reproductive equity is long overdue and how Plan A™ is poised to spark a cultural shift.

READ MORE ON: XRAISED

Next
Next

THE AUSTRALIAN SUN | NEXT Life Sciences Announces Successful Plan A™ Delivery Device Clinical Trial in Australia